June. 03, 2020 |
|
Mar. 31, 2023 |
|
jRCTs042200014 |
Examination of the usefulness of right ventricular septal pacing using a delivery catheter |
|
Examination of the usefulness of right ventricular septal pacing using a delivery catheter |
Mar. 18, 2021 |
|
70 |
|
There were 70 subjects in the study. The mean age was 78+-11 years (31-97 years). There were 30 males and 40 females. Atrioventricular block was classified as grade I in 0 patients, Wenckebach in 0 patients, Mobitz in 2 patients, severe in 21 patients, and grade III in 47 patients. Left ventricular ejection fraction measured by echocardiography was 64;+-8% on average. Ventricular lead implantation was performed as per allocation in all patients, and no crossover was observed. There was no bias in comorbidities or laboratory findings between the two groups, and background factors were well adjusted by random assignment. |
|
The registration status was good and was completed earlier than the planned registration period. The number of patients enrolled per institution was 17-20% at Juntendo University Shizuoka Hospital, Chutoen General Medical Center, and Shizuoka Medical Center, and 10% at other institutions. A total of 70 patients were enrolled in the study, and 69 patients completed the study; one patient was discontinued by lead dislodgment and withdrew consent. |
|
The total number of events was 3 (including 3 serious diseases). In the stylet group, there were 2 cases of lead dislodgment and 1 case of wound complication. In the delivery catheter group, there was one case of Takotsubo cardiomyopathy. |
|
(Primary endpoint) Successful septal placement of ventricular lead tip as assessed by cardiac CT (percentage and actual number) Delivery catheter group 78% (28/36) vs. stylet group 50% (17/34) p=0.024 (Secondary endpoints) QRS width of pacing (and incremental QRS width of pacing compared with pre-implantation QRS width) (mean +- standard deviation) QRS width of pacing (and incremental QRS width of pacing compared to pre-implantation QRS width) (mean +- standard deviation) Delivery catheter group 129 +- 20 ms vs. stylet group 142 +- 15 ms p=0.003 Surgical time (median and quartiles) Delivery catheter group 91 (68-119) min vs. stylet group 85 (59-118) min; p=0.488 Fluoroscopy time (median and quartile) Median and quadrant fluoroscopy time (delivery catheter group 18 (12-24) min vs. stylet group 13 (10-22) min; p=0.129) Ventricular lead screw-in frequency (median and quartiles) Median and quartile ventricular lead screw-in frequency (delivery catheter group 1 (1-2) vs. 1 (1-2) in the stylet group; p=0.749) Ventricular lead height, threshold, and impedance at implantation and discharge (mean +- standard deviation) <At implantation Wave height: delivery catheter group 10.9+-4.3 mV vs. stylet group 9.3+-4.7 mV; p=0.176 Threshold: 0.68+-0.31 V for delivery catheter vs. 0.64+-0.23 V for stylet; p=0.608 Impedance: Delivery group 690+-97ohm vs. Stylet group 622+-130ohm p=0.016 <At discharge Wave height: delivery catheter group 13.8+-4.8 mV vs. stylet group 11.5+-4.8 mV; p=0.079 Threshold: 0.72+-0.32 V for delivery catheter vs. 0.75+-0.23 V for stylet; p=0.703 Impedance: delivery catheter group 567+-69ohm vs. stylet group 568+-106ohm p=0.943 Incidence of abnormal ventricular lead position at hospital discharge (percentage and actual number) Delivery catheter group 0% (0/36) vs. stylet group 3% (1/34) p=0.486 |
|
The primary endpoint of successful septal placement of the ventricular lead tip as assessed by cardiac CT was significantly higher in the delivery catheter group compared to the stylet group (p=0.024). In the secondary endpoints, the QRS width of pacing was significantly narrower in the delivery catheter group (p=0.003). In lead measurements, impedance at implantation was significantly lower in the delivery catheter group, but there was no significant difference at discharge. |
|
Mar. 31, 2023 |
|
No |
|
No |
|
https://jrct.niph.go.jp/latest-detail/jRCTs042200014 |
Naruse Yoshihisa |
||
Hamamatsu University School of Medicine |
||
1-20-1,Handayama,Higashi-ku,Hamamatsu city,Shizuoka |
||
+81-53-435-2356 |
||
ynaruse@hama-med.ac.jp |
||
Naruse Yoshihisa |
||
Hamamatsu University School of Medicine |
||
1-20-1,Handayama,Higashi-ku,Hamamatsu city,Shizuoka |
||
+81-53-435-2356 |
||
ynaruse@hama-med.ac.jp |
Complete |
June. 03, 2020 |
||
June. 16, 2020 | ||
70 | ||
Interventional |
||
randomized controlled trial |
||
single blind |
||
active control |
||
parallel assignment |
||
treatment purpose |
||
1. Patients over 20 years old |
||
1. Patients with severely reduced cardiac function (left ventricular ejection fraction [LVEF] <35%) |
||
20age old over | ||
No limit | ||
Both |
||
Atrioventricular block |
||
To evaluate the position of the tip of the ventricular lead using a delivery catheter type lead or stylet type lead in patients scheduled to undergo pacemaker implantation. Assignment is randomized. |
||
Success rate of septal placement at the tip of the ventricular lead evaluated by cardiac CT |
||
Pacing QRS width |
Medtronic Japan Co., Ltd. | |
Applicable |
Clinical Research Review Board of Hamamatsu University School of Medicine | |
1-20-1,Handayama,Higashi-ku,Hamamatsu, Shizuoka | |
+81-53-435-2680 |
|
kenkyou.s@hama-med.ac.jp | |
Approval | |
April. 17, 2020 |
none |